Respiratory Secretions. Care in the last 72 hours of life Paul Tait, pharmacist

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital.

Managing Respiratory Symptoms - Breathlessness, Cough and Secretions. Dr Laura Healy. Palliative Medicine Registrar, Beaumont Hospital. Things to consider: 1. Very common symptoms. 2. Can occur in any

PAIN MANAGEMENT Patient established on oral morphine or opioid naive.

PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

Anticipatory Medications for End of Life Patients. Doses must be proportional to the current analgesic medication YES NO YES NO

Anticipatory Medications for End of Life Patients oses must be proportional to the current analgesic medication Please refer ALL patients on Methadone or Ketamine to palliative care team for advice. Patients

Renal Palliative Care Last Days of Life

Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr

Algorithms for Symptom Management. In End of Life Care

Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member

Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life

Guidance for Anticipatory prescribing for patients in renal failure (egfr

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT

ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients

SYRINGE DRIVER MEDICATIONS

SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015 Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil

End Stage Liver Disease Regional Audit Casenote Survey

1. This questionnaire is an audit of clinical documentation of patients who have died of end stage liver disease. If you have any questions about how this form should be completed please contact Dr Grace

Syringe driver in Palliative Care

Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24

Care in the Last Days of Life

Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT

PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be

Symptom Management Guidelines for End of Life Care

Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A

Regional Palliative Care Services

Page 1 September 2018 - Issue 43 Regional Palliative Care Services In This Issue: Respiratory Congestion Northern Lights in Palliative Care Featuring: Jessica Fitterer, LPN Educational Opportunities Webinars

Anticipatory prescribing and end of life considerations. Dr Stephanie Lippett

Anticipatory prescribing and end of life considerations Dr Stephanie Lippett contents Pain Restlessness/agitation Nausea/vomiting Secretions Syringe driver Anticipatory prescribing Important things to

Palliative Care Impact Survey

September 2018 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Clinical Guideline Early recognition of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER

Care of dying adults in the last days of life. Improving care at the very end of life.

Care of dying adults in the last days of life Improving care at the very end of life. Foreword We will all experience death, whether it is our own or that of a loved one. The bereaved person s perception

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)

GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative

Supportive Care. End of Life Phase

Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of

End of life prescribing guidance

End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly

CLINICAL GUIDELINES FOR END OF LIFE CARE MEDICATIONS IN LONG TERM CARE HOMES

CLINICAL GUIDELINES F END OF LIFE CARE MEDICATIONS IN LONG TERM CARE HOMES OPENING STATEMENT: Insert Facility Name is committed to providing effective end-of-life symptom management to all residents. Symptom

EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved

Palliative Care. Anticipatory Prescribing Guidelines & June Gippsland Region Palliative Care Consortium Clinical Practice Group

Palliative Care Anticipatory Prescribing Guidelines June 2016 Gippsland Region Palliative Care Consortium Clinical Practice Group Policy No. Title Keywords Ratified GRPCC-CPG008_1.1_2016 Anticipatory Prescribing

Implementing the recommendation on medication management and symptom control

Implementing the recommendation on medication management and symptom control Mike Grocott Professor of Anaesthesia and Critical Care Medicine University of Southampton Consultant in Critical Care Medicine

This survey aims to look at individual practice and can be completed by any healthcare professional.

This survey aims to look at individual practice and can be completed by any healthcare professional. If you have any questions about how this form should be completed please contact Dr Grace Ting (ghlting@doctors.net.uk)

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE

PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Originally produced: July 2006 First Review: August 2009 Second Review: November 2011 For review November 2013 Approved

Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.

Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.

Care of the Dying Management in Severe Renal Failure

Care of the Dying Management in Severe Renal Failure Clinical Guideline Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance

UMC Health System Patient Label Here. PHYSICIAN ORDERS Diagnosis

Diagnosis Weight Allergies Patient Care Vital Signs Per Unit Standards q12h q12h, Temperature Only - Every Shift and PRN Patient Activity Assist as Needed, Bed Position: As Tolerated, elevate to patient

Palliative care for heart failure patients. Susan Addie

Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves

Symptom Control and End of Life Care

Symptom Control and End of Life Care MND Special Interest Groups Workshop Dr Cynthia Parr Staff Specialist in Palliative Medicine 12 September 2013 The best test of a physician s suitability for the specialized

Clatterbridge Centre for Oncology

Clatterbridge Centre for Oncology CONTENTS 1. Why and when to use a syringe driver 2. Siting the syringe driver 3. Mixing and measuring 4. Setting up the syringe driver 5. Drug information 6. Common problems

Conservative Management of Uraemia

Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist

Target audience: The target audience for this guidance are: GPs Care home managers and nurses, District nurses, and Specialist Palliative Care teams.

Anticipatory medication guidance for the last days of life for frail older people being care for in care homes who do not have Specialist Palliative Care needs Purpose of guidance: The purpose of this

Death rattle: critical review and research agenda

Support Care Cancer (2014) 22:571 575 DOI 10.1007/s00520-013-2047-5 REVIEW ARTICLE Death rattle: critical review and research agenda Sebastiano Mercadamte Received: 19 September 2013 /Accepted: 31 October

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC) May 2018 THE WATERLOO WELLINGTON SYMPTOM MANAGEMENT GUIDELINE FOR THE END OF

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients. The closing date for responses is 19th December The results

Isle of Wight Syringe Driver Compatibility Guidelines

Isle of Wight Syringe Driver Compatibility Guidelines Produced by The Earl Mountbatten Hospice, Isle of Wight Written January 2015, revision due January 2018 This guideline is available as a paper pocketbook

BREATHLESSNESS MANAGEMENT

Guideline Name: Breathlessness BACKGROUND Breathlessness is a common symptom in patients with cancer, end-stage heart failure and end-stage chronic obstructive pulmonary disease (COPD). There are many

Opioids in the Community: Chronic pain, Palliative Care, and Addiction. Dr Ahmed Jakda September 2017

Opioids in the Community: Chronic pain, Palliative Care, and Addiction Dr Ahmed Jakda September 2017 Outline Context Background Action Delisting Highstrength Long- Acting Opioids Opioid use and prescribing

Regional Renal Training

Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing

Using syringe pumps in palliative care

Using syringe pumps in palliative care Facilitator: Barbara Stone RN Ground rules Medication matching game Learning outcomes To identify the indications for using a syringe pump To discuss the general

The last days of life in hospital and at home

The last days of life in hospital and at home Beaumont Multi-disciplinary Palliative Care Study Day 28/9/2017 Dr Sarah McLean Consultant in Palliative Medicine St Francis Hospice Beaumont Hospital Overview

UMC Health System Patient Label Here PHYSICIAN ORDERS

Diagnosis Weight Allergies Patient Care Vital Signs Per Unit Standards q12h q12h, Temperature Only - Every Shift and PRN Patient Activity Assist as Needed, Bed Position: As Tolerated, elevate to patient

Restlessness Emotional support Self care

Comfort Airway Restlessness Emotional support Self care MED 12412 9/12 City of Hope Department of Supportive Care Medicine 1500 Duarte Road Duarte, CA 91010 August 2012 The following are recommendations

B.C. INTER-PROFESSIONAL PALLIATIVE SYMPTOM MANAGEMENT GUIDELINES

B.C. INTER-PROFESSIONAL PALLIATIVE SYMPTOM MANAGEMENT GUIDELINES Copyright BC Centre for Palliative Care. 2017. 300-601 Sixth St. New Westminster, B.C. V3L 3C1. office@bc-cpc.ca please see Introduction

SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:

FILE IN PATIENT S COMMUNITY HEALTH RECORD FOLDER : SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRERIPTION & ADMINISTRATION RECORD (SPAR) Abbreviations used in this document to be listed here with the full

BACKGROUND Measuring renal function :

A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

The last days of life Linda Magann CNC Palliative Care St George Hospital I m not afraid of dying, I just don t want to be there when it happens Woody Allen Palliative Care is an approach that improves

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT

INTEGRATED CARE PATHWAY (ICP) FOR THE DYING ADULT PLEASE INFORM THE PALLIATIVE CARE TEAM ON COMMENCEMENT OF THIS ICP (EXT 8958) ICP Start Date Patient s Name. Ward. Consultant.. Named Specialist Nurse

Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30

If more information is required please seek help from specialist palliative care pioid dose conversion chart, syringe driver doses, rescue/prn doses and opioid patches Use the conversion chart to work

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

Incidence and aetiology:

A pilot randomised cross-over double blinded controlled efficacy study of Octreotide versus hyoscine hydrobromide in controlling respiratory secretions at the end of life Katherine Clark, David Currow,

Symptom Control in the Community Setting. Dr Andrew Tysoe-Calnon

Symptom Control in the Community Setting Dr Andrew Tysoe-Calnon Lead Consultant t Common symptoms Pain Agitation Shortness of breath Nausea and vomiting Intestinal obstruction Confusion Pain Occurs in

APHN. Shortness of breath. Ednin Hamzah CEO, Hospis Malaysia.

APHN Shortness of breath Ednin Hamzah CEO, Hospis Malaysia ednin@hospismalaysia.org What is it? a subjective experience of difficult and uncomfortable breathing American Thoracic Society What do the patients

Palliative Care. Pocketbook 4

Nottinghamshire STP EOL Programme Board 2019 Review 2022 Palliative Care Pocketbook 4 Contents Pain Guidelines page 2 Nausea and Vomiting page 9 Inoperable Bowel Obstruction page 10 Constipation page 11

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117

GUIDELINES & PROTOCOLS

GUIDELINES & PROTOCOLS ADVISORY COMMITTEE Palliative Care for the Patient with Incurable Cancer or Advanced Disease Part 2: Pain and Symptom Management Dyspnea Effective Date: September 30, 2011 Scope

SYMPTOM CONTROL IN THE LAST DAYS OF LIFE. Bradford, Airedale, Wharfedale & Craven

Bradford, Airedale, Wharfedale & Craven Managed Clinical Network SYMPTOM CONTROL IN THE LAST DAYS OF LIFE Guidelines for Healthcare Professionals Bradford, Airedale, Wharfedale & Craven Signs and symptoms

Essential Syringe Driver Training for T 34. Elaine Bird St Luke s Hospice

Essential Syringe Driver Training for T 34 Elaine Bird St Luke s Hospice Aim For all practitioners to be accountable for their individual competence and capability when caring for a resident with a T34

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Doncaster & Bassetlaw Cancer Locality Palliative Core Formulary Approved by Doncaster & Bassetlaw Hospitals NHS Foundation Trust Drugs and Therapeutics Committee. DJ14/2155 Oct 2014 Review date: Oct 2017

In our patients the cause of seizures can be broadly divided into structural and systemic causes.

Guidelines for the management of Seizures Amalgamation and update of previous policies 7 (Seizure guidelines, ND, 2015) and 9 (Status epilepticus, KJ, 2011) Seizures can occur in up to 15% of the Palliative

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110

Berkshire Adult Palliative Care Guidelines - End of Life Care GL110 Approval Approval Group Job Title, Chair of Committee Date Drugs & Therapeutic Committee Chair, Drugs & Therapeutic Committee October

Primary Diagnosis YES NO ICD - Code Cancer Cognitive impairment Cardiac Respiratory Neurological Musculoskeletal Respiratory Other

Chart review date: / / Reviewer: Centre Name: Hospital Home RACF DOB: / / AGE: GENDER: Male Female Admission Date: / / Death Date: / / 1. DIAGNOSIS Primary Diagnosis YES NO ICD - Code Cancer Cognitive

MND Just in Case kit Information for GPs

MND Just in Case kit Information for GPs What is the MND Just in Case kit? 2 Motor neurone disease (MND) is a progressive and terminal disease that results in degeneration of the motor neurones in the

A SLP s Guide to Medication Therapy and Management. Sarah Luby, PharmD, BCPS KSHA 2017

A SLP s Guide to Medication Therapy and Management Sarah Luby, PharmD, BCPS KSHA 2017 Objectives Identify the appropriate route of administration for medications and proper formulations for use Understand

Preparing for Approaching Death

Preparing for Approaching Death Old Colony Hospice created this guide for our hospice family and caregivers by revising and adapting the following journal article: Hospice Techniques: Preparing for the

Palliative Care Out-of-hours. A resource pack for West Dorset. Contents:

Palliative Care Out-of-hours. A resource pack for West Dorset Contents: Section 1 Supply of drugs DCH Pharmacy hours and arrangements How to contact a community pharmacist out of hours Palliative care

End of Life Care. Dr Anne Garry Consultant in Palliative Medicine

End of Life Care Dr Anne Garry Consultant in Palliative Medicine Concerns voiced both by public and professionals.. Implementation and on-going training highly variable across country Decisions made by

CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC

CARE OF THE DYING PATIENT WITH ESKD ELIZABETH JOSLAND - RSC CNC OBJECTIVES UNDERSTANDING OF: POTENTIAL COMPLEXITIES OF ESKD PATIENTS IMPORTANCE OF COMMUNICATION CONSIDERATIONS AT END-OF-LIFE END-OF-LIFE

Opioid Conversion Ratios - Guide to Practice 2010

Opioid Conversion Ratios - Guide to Practice 2010 Released December 2010. 2010. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that

Palliative Approach Toolkit: A framework for a palliative approach to care in residential aged care facilities

Palliative Approach Toolkit: A framework for a palliative approach to care in residential aged care facilities Professor Liz Reymond MBBS (Hons), MSc, PhD, FRACGP, FAChPM Brisbane South Palliative Care

Respiratory Pharmacology. Manuel Otero Lopez Department of Anaesthetics and Intensive Care Hôpital Européen Georges Pompidou, Paris, France

Respiratory Pharmacology Manuel Otero Lopez Department of Anaesthetics and Intensive Care Hôpital Européen Georges Pompidou, Paris, France Programme Bronchomotor tone Drugs and factors influencing airway

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline 1. Pharmacist to order Narcotic Withdrawal Scores QH X 4 hours, then per table below: Narcotic Withdrawal Score

Approximate Cost for Patients

Insurance Coverage for Prescriptions Medications that enhance control of pain and symptoms may be costly if patients do not have insurance. In Ontario, the Ontario Drug Benefit (ODB) Program covers prescriptions

Inpatient Palliative Medicine Update

Inpatient Palliative Medicine Update David Dupere MD, FRCPC Head, Division of Palliative Medicine Department of Medicine QEII Health Sciences Centre Halifax, Nova Scotia Disclosures Book chapter in Compendium

Opioids silent killers?

Opioids silent killers? Jason Boland Senior clinical lecturer and honorary consultant in palliative medicine Hull York Medical School and North East Lincolnshire, UK Does it depend on the situation? Opioids

Policy/Standard Operating Procedure/ Clinical Guideline. ELHT/CP22 Version 5.1. ELHT/CP22 Version 4.1

TRUST WIDE/DIVISIONAL DOCUMENT Delete as appropriate Policy/Standard Operating Procedure/ Clinical Guideline DOCUMENT TITLE: Policy and Procedure for the T34 Ambulatory Syringe Pump in adults (Palliative

Approach to symptom control near the end-of-life

Approach to symptom control near the end-of-life 18 Sept 2011 Dr Alethea Yee Senior Consultant, Department of Palliative Medicine National Cancer Centre,Singapore What is end of life? No precise definition

The Death Rattle Dilemma

2.5 ANCC Contact Hours The Death Rattle Dilemma Flannery Fielding, MS, NP, ACHPN ƒ Carol O. Long, PhD, RN, FPCN, FAAN Death rattle, defined as the noise created by the flow of air through secretions in

Dr. A. Kerigan BREATHLESSNESS AT THE END OF LIFE

Dr. A. Kerigan BREATHLESSNESS AT THE END OF LIFE Faculty/Presenter Disclosure Faculty: Dr. A. Kerigan Relationships with commercial interests:* - Grants/Research Support: None - Speakers Bureau/Honoraria:

What s New 2003? What new treatments? What have you discontinued? More information please!

What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?

Hospice High Dollar Medications and Possible Alternatives

Hospice High Dollar Medications and Possible Alternatives Ly M. Dang, PharmD LDang@HospicePharmacySolutions.com Director of Pharmacy Operations Hospice Pharmacy Solutions Topics of Discussion Hospice Coverage

Understanding Respiratory Illnesses

Understanding Respiratory Illnesses Respiratory illnesses and the people you support Is a major cause of unplanned hospitalizations. Usually occur in fall and winter. It is important for you to Help people

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine

PACKAGE LEAFLET Package leaflet: Information for the user Ranitidin Actavis 150 mg and 300 mg film-coated tablets Ranitidine Read all of this leaflet carefully, before you start taking this medicine because

PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)

PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) 1. What is the main problem that you are having? (If additional space is required, please use the back of this

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist

Alternative Routes of Drug Administration (analgesia) Dr Andrew Dickman Consultant Pharmacist Alternative Routes of Drug Administration Introduction Subcutaneous Route Contemporary Issues Compatibility

Analgesics: Management of Pain In the Elderly Handout Package

Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed